N-(4-{[(2,4-Diamino-6-pteridinyl)methyl](methyl)amino}benzoyl)glutamic acid(CAS番号:60388-53-6)
基本情報
amino}benzoyl)glutamic acid N-(4-{[(2,4-Diamino-6-pteridinyl)methyl](methyl)amino}benzoyl)glutamic acid](/structs/603/60388-53-6-37ec.webp)
CAS番号
60388-53-6
分子式
C20H22N8O5
分子量
454.45 g/mol
Quick Actions
基本的な物理特性
融点
195 °C (dec.)(lit.)
安全情報
安全情報を表示同義語と参考文献
英語
- NCGC00095284-01
- Kyselina 4-amino-N10-methylpteroylglutamova
- BRD-A55424491-001-08-2
- 6-Mtx (DL)
- Methotrexate (hydrate)
- (+/-)Amethopterin
- Methotrexate pound>>Amethopterin
- HMS3713K07
- Methotrexate2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid
- Folex (Salt/Mix)
- NCGC00015079-03
- Amethopterin; DL-Amethopterin
- Prestwick3_000373
- SMR001565548
- DL-Methotrexate
- SR-05000001673-2
- METHOTREXATE(+/-)
- Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-
- DL-MTX
- HMS3403O03
- NSC117356
- SCHEMBL20369096
- 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid(methotrexate(MTX))
- 4-Amino-N10-methylpteroylglutamic acid
- 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid(MTX)
- Glutamic acid, N-(p-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-, DL-
- BCP29918
- NSC 117356
- Prestwick3_000135
- 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid (MTX)
- CHEBI:93775
- FBOZXECLQNJBKD-UHFFFAOYSA-N
- Q27165469
- Folex
- NCI60_041622
- HMS1920L21
- N-(p-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)-DL-glutamic acid
- HMS2091D16
- Prestwick_753
- CCG-212689
- 2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid
- BSPBio_000525
- BSPBio_001993
- 99ITO15X8S
- Prestwick0_000373
- SR-05000001673
- HMS2096K07
- BPBio1_000232
- DL-Amethopterin
- BDBM50004545
- N-(4-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)-DL-glutamic acid
- SCHEMBL11986730
- (+)-Amethopterin
- N-(4-{[(2,4-Diaminopteridin-6-yl)methyl](methyl)amino}benzoyl)glutamic acid
- HMS3869E13
- 60388-53-6
- ChEMBL_59579
- Prestwick1_000373
- 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid(Methotrexate, MXT)
- 2-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)formamido]pentanedioic acid
- EINECS 262-213-7
- UNII-99ITO15X8S
- SCHEMBL3712
- BSPBio_000210
- N-(4-(((2,4-DIAMINO-6-PTERIDINYL)METHYL)METHYLAMINO)BENZOYL)GLUTAMIC ACID
- (+-)-Methotrexate
- GLUTAMIC ACID, N-(4-(((2,4-DIAMINO-6-PTERIDINYL)METHYL)METHYLAMINO)BENZOYL)-
- Prestwick2_000373
- NCGC00095284-02
- TCMDC-125488
- 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid(Amethopterin)
- (MTX)2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid
- Glutamic acid, N-[p-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, L-(+)-
- Methotrexate;DL-Amethopterin
- FT-0601523
- NSC-117356
- HMS1569K07
- SBI-0053664.P003
- (+/-)-METHOTREXATE
- 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid(Methotrexate )
- BDBM50600679
- DL-Glutamic acid, N-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-
- 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid bis-adamantan-1-ylamide
- 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid(Methotrexate)
- AC-11680
- EN300-296152
- TCMDC-123832
- MLS002701970
- NSC757113
- HMS3371G08
- HMS3267F07
- 4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol(methotrexate, MTX)
- SPBio_002446
- 2-(4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioicacid
- 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid(Methotrexate (MTX))
- Amethopterin (hydrate); CL14377 (hydrate); WR19039 (hydrate)
- CHEMBL426
- AKOS000281496
- 2-[[[4-[(2,4-diamino-6-pteridinyl)methyl-methylamino]phenyl]-oxomethyl]amino]pentanedioic acid
- SPECTRUM1500398
- (methotrexate)2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid
- N-(p-((2,4-Diamino-6-pteridyl)methyl)methylamino)benzoyl)glutamic acid, (L)-
- Methotrexate, (+/-)-
- NS00001328
- SR-05000001673-1
- NCGC00015079-04
- Pharmakon1600-01500398
- DTXSID40859034
- HMS3654M22
- M1664
- 2-(4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid
- D(-)-AMETHOPTERIN
- N-(4-[[(2,4-Diamino-6-pteridinyl)methyl](methyl)amino]benzoyl)glutamic acid, (L)-
- 2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid (Methotrexate)
- Amethopterin
- L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-
- NCGC00015079-07
- FT-0630651
- BCP02078
- BRD-A55424491-001-07-4
- BPBio1_000579
- Amethopterin (R,S)
- AKOS024282621
- AB02593
- NSC-757113
- (Methotrexate, MTX)2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid
- N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-DL-glutamic acid
- DL-Methotrexate Dipotassium Salt Dihydrate
- (+/-)AMETHOPTERIN
- (±)AMethopterin hydrate
- (plus-Minus)-aMethopterin(-20`C)
- 2S,5S-Methionine sulfoximine
- 4-amino-10-methylpteroyl-glutamic acid
- 4-amino-N10-methylpteroylglutamic acid
- D-methionine-R-sulfoximine
- D-Methotrexat
- (4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzoyl)glutamic acid
MDL_Number
MFCD00064369
CAS番号
60388-53-6
サプライヤー情報
サプライヤー名 | 会員レベル | 認証状況 | 主要カテゴリー | 最小注文数量 | アクション |
---|---|---|---|---|---|
関連論文
An aminophosphonate ester ligand-containing platinum(ii) complex induces potent immunogenic cell death in vitro and elicits effective anti-tumour immune responses in vivo
Ke-Bin Huang, Feng-Yang Wang, Hai-Wen Feng, Hejiang Luo, Yan Long, Albert S. C. Chan, Rong Liu, Huahong Zou, Zhen-Feng Chen, Yan-Cheng Liu, You-Nian Liu, Hong Liang
DOI: 10.1039/C9CC06563F
Recent developments in carbon nitride based films for photoelectrochemical water splitting
Rui-Qin Zhang
DOI: 10.1039/C9SE00785G
A model-based comparison of Ru and Ni catalysts for the Sabatier reaction
DOI: 10.1039/C9SE00787C
Increasing efficiency of perovskite solar cells using low concentrating photovoltaic systems
Hasan Baig, Hiroyuki Kanda, Abdullah M. Asiri, Mohammad Khaja Nazeeruddin, Tapas Mallick
DOI: 10.1039/C9SE00550A
Redox responsive Pluronic micelle mediated delivery of functional siRNA: a modular nano-assembly for targeted delivery
Sandeep Kadekar, Ganesh N. Nawale, Vadim Le Joncour, Pirjo Laakkonen, Jöns Hilborn, Oommen P. Varghese, Oommen P. Oommen
DOI: 10.1039/D1BM00428J
MnO/C cubo-polyhedrons derived from α-MnO2@ZIF-8 as anode materials for high-performance lithium-ion batteries
Lei Zhang, Jiaoyu Xiao
DOI: 10.1039/C9SE00637K
Strong circularly polarized luminescence of an octahedral chromium(iii) complex
Carolin Dee, Francesco Zinna, Winald R. Kitzmann, Gennaro Pescitelli, Katja Heinze, Lorenzo Di Bari, Michael Seitz
DOI: 10.1039/C9CC06909G
Synthesis of aviation fuel from bio-derived isophorone
Courtney Ford Ryan, Cameron M. Moore, Juan H. Leal, Troy A. Semelsberger, Jenny K. Banh, Junqing Zhu, Charles S. McEnally, Lisa D. Pfefferle, Andrew D. Sutton
DOI: 10.1039/C9SE01014A
Non-aqueous neptunium and plutonium redox behaviour in THF – access to a rare Np(iii) synthetic precursor
Nickolas H. Anderson, Suzanne C. Bart, Andrew J. Gaunt, Brian L. Scott
DOI: 10.1039/C8CC02611D
Insights into the mechanism of photosynthetic H2 evolution catalyzed by a heptacoordinate cobalt complex
Fiorella Lucarini, Jennifer Fize, Adina Morozan, Mirco Natali, Mariachiara Pastore, Vincent Artero, Albert Ruggi
DOI: 10.1039/C9SE00434C